Wellmedr vs Embody: Compare Pricing, Shipping and Guarantees
Quick verdict: Wellmedr positions itself on lifetime locked pricing and a money back guarantee plus same-day review and overnight shipping, while Embody undercuts on entry price with semaglutide at $69/month and free 1-2 day delivery. The right choice depends on whether you value guaranteed pricing and refund terms or the lowest advertised monthly entry price.
Explore Wellmedr plans and pricing
How Wellmedr vs Embody differ at a glance
This comparison focuses on the most distinctive, supported differences between Wellmedr and Embody: advertised starting price and promotions, shipping and review timing, premium guarantees and pricing locks, and the regulatory status of compounded medications.
Comparison table
| Criteria | Wellmedr | Embody |
|---|---|---|
| Advertised starting price | GLP-1 Plans starting at $89/month; Semaglutide listed in text starting at $49/month | $69/month for compounded semaglutide (was $299) |
| Shipping and review timing | Same-day review plus free overnight shipping | Free shipping; arrives in 1–2 days after approval |
| Pricing commitments and promotions | Lifetime locked-in pricing; New customer offer: $150 off for life; promotional Labor Day messaging | Flat locked in monthly pricing stated; $69 semaglutide described as a limited-time offer |
| Guarantees and refund claims | Money back guarantee claimed: “If you do not lose weight in 90 days we will refund 100% of your money” on landing content | No comparable money back guarantee captured |
| Medication type and regulatory note | Offers compounded GLP-1 medications from licensed U.S. pharmacies; notes compounded medications are not evaluated by the FDA for safety or efficacy | Compounded semaglutide and tirzepatide; notes compounded medications are not FDA-approved finished products |
Pricing and promotions compared
Wellmedr advertises GLP-1 plans starting at $89/month and promotional messaging including a Labor Day sale and a new customer offer to lock in $150 off for life. The landing content also lists semaglutide monthly plans with a starting point of $49 a month. Embody advertises a lower entry price for compounded semaglutide at $69/month, stated as cut from $299, and tirzepatide at $119/month. Embody describes the $69 price as a limited-time offer and notes final pricing may vary based on dose and clinician recommendation. Use only these captured pricing claims when deciding which entry price fits your budget.
Shipping and clinician review speed
Both providers highlight fast fulfillment but describe it differently. Wellmedr promotes same-day review plus free overnight shipping, while Embody advertises free shipping that arrives in 1 to 2 days after clinician approval. If approval speed and next-day delivery are decisive, the landing evidence places Wellmedr and Embody on different timelines in their own claims.
See Embody pricing and shipping details
Guarantees, features and service differences
Wellmedr emphasizes lifetime locked-in pricing and a money back claim tied to a 90 day outcome in its captured content, along with on-time refills and discreet delivery language. Embody emphasizes a straightforward, low-cost model with no long-term membership, cancel anytime language, licensed provider review online, and 24/7 support access for dosing and side-effect questions as described in captured content. Embody also notes fewer premium features such as integrated coaching compared with higher-priced platforms.
Regulatory and medication notes
Both providers’ captured content makes clear the products offered are compounded GLP-1 medications. Wellmedr states compounded medications are regulated by state Boards of Pharmacy but are not evaluated by the FDA for safety or efficacy. Embody states compounded medications are not FDA-approved finished products. Both include this regulatory qualifier and indicate treatment requires clinician review and prescription where applicable.
Final comparison and recommendation
Wellmedr vs Embody comes down to a trade-off between pricing and guarantees. Embody is the lower advertised entry price for semaglutide at $69/month with fast 1 to 2 day shipping and a no-membership model. Wellmedr emphasizes lifetime locked pricing, same-day review plus overnight shipping, and a money back claim tied to a 90 day outcome in captured content. Both providers offer compounded GLP-1 medications and include regulatory notes that compounded products are not evaluated by the FDA.
Choose one if
Choose Embody if you want the lowest advertised semaglutide entry price at $69/month, free fast shipping in 1 to 2 days after approval, and a lean, cancel anytime telehealth model focused on cost.
Choose Wellmedr if you prioritize lifetime locked-in pricing, same-day clinician review plus free overnight shipping, and the specific landing-page money back claim captured in the provider evidence.
This comparison uses only captured landing content and stated claims from each provider. All treatment plans require medical evaluation and clinician approval as shown in the source content. Compounded medications are not FDA-approved finished products and are subject to the regulatory notes included above.
Primary keyword: Wellmedr vs Embody